UnitedHealth Group Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>UnitedHealth Group Inc. has filed its Q1 2024 10-Q report.</b>

AI Summary

UNITEDHEALTH GROUP INC (UNH) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. UnitedHealth Group Inc. filed its quarterly report (10-Q) for the period ending March 31, 2024. The filing covers the first quarter of 2024. The company's principal executive offices are located in Minnetonka, MN. UnitedHealth Group Inc. was formerly known as United HealthCare Corp. The company operates within the Hospital & Medical Service Plans industry.

Why It Matters

For investors and stakeholders tracking UNITEDHEALTH GROUP INC, this filing contains several important signals. This filing provides an update on the company's financial performance and operational status for the first quarter of 2024. Investors and analysts can use this report to assess UnitedHealth Group's current financial health and strategic direction.

Risk Assessment

Risk Level: low — UNITEDHEALTH GROUP INC shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate red flags or significant negative developments.

Analyst Insight

Monitor future filings for detailed financial results and management commentary on performance drivers and outlook.

Key Numbers

• 2024-03-31 — Period End Date (Quarterly report period)
• 2024-05-09 — Filing Date (Date the report was filed)
• 2024-01-01 — Quarter Start Date (Beginning of the reporting period)
• 2023-12-31 — Previous Year End Date (End of the prior fiscal year)

Key Players & Entities

• UNITEDHEALTH GROUP INC (company) — Filer name
• 0000731766-24-000155 (filing_id) — Accession number
• 20240331 (date) — Period of report
• 20240509 (date) — Filed as of date
• MINNEAPOLIS (location) — Business address city
• MN (location) — Business address state
• 55343 (postal_code) — Business address zip
• UNITED HEALTHCARE CORP (company) — Former company name

FAQ

Industry Context

UnitedHealth Group operates in the healthcare industry, specifically within Hospital & Medical Service Plans, a sector characterized by evolving regulations and significant market demand.

Regulatory Implications

As a major healthcare provider, UnitedHealth Group is subject to extensive regulatory oversight from federal and state agencies concerning health insurance, Medicare, and Medicaid programs.

What Investors Should Do

1. Review the full 10-Q filing for detailed financial statements and segment information.
2. Analyze management's discussion and analysis (MD&A) for insights into performance drivers and risks.
3. Compare Q1 2024 results with prior periods and analyst expectations.

Key Dates

• 2024-03-31: Quarter End — End of the reporting period for the 10-Q filing.
• 2024-05-09: Filing Date — Date the 10-Q was officially submitted to the SEC.

Year-Over-Year Comparison

This is the initial 10-Q filing for the fiscal year 2024, following the 2023 annual report.

Filing Documents

• unh-20240331.htm (10-Q) — 1160KB
• ex311unh2024331.htm (EX-31.1) — 19KB
• ex321unh2024331.htm (EX-32.1) — 9KB
• unh-20240331_g1.jpg (GRAPHIC) — 16KB
• 0000731766-24-000155.txt (&nbsp;) — 6526KB
• unh-20240331.xsd (EX-101.SCH) — 25KB
• unh-20240331_cal.xml (EX-101.CAL) — 82KB
• unh-20240331_def.xml (EX-101.DEF) — 220KB
• unh-20240331_lab.xml (EX-101.LAB) — 513KB
• unh-20240331_pre.xml (EX-101.PRE) — 364KB
• unh-20240331_htm.xml (XML) — 1018KB

Financial Information

Part I. Financial Information Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) 1 Condensed Consolidated Balance Sheets as of March 3 1 , 202 4 and December 31, 202 3 1 Condensed Consolidated Statements of Operations for the Three Months Ende d March 3 1 , 202 4 and 202 3 2 Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 3 1 , 202 4 and 2 023 3 Condensed Consolidated Statements of Changes in Equity for the Three Months Ended March 3 1 , 202 4 and 202 3 4 Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 3 1 , 202 4 and 202 3 5 Notes to the Condensed Consolidated Financial Statements 6 1. Basis of Presentation 6 2. Investments 7 3. Fair Value 9 4. Medical Costs Payable 10 5. Short-Term Borrowings and Long-Term Debt 10 6 . Commitments and Contingencies 11 7 . Disposition 12 8 . Segment Financial Information 13 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 14 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 22 Item 4.

Controls and Procedures

Controls and Procedures 22

Other Information

Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 22 Item 1A.

Risk Factors

Risk Factors 22 Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 23 Item 5. Other Information 23 Item 6. Exhibits 24

Signatures

Signatures 25 PART I

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS UnitedHealth Group Condensed Consolidated Balance Sheets (Unaudited) (in millions, except per share data) March 31, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 28,414 $ 25,427 Short-term investments 4,296 4,201 Accounts receivable, net 27,197 21,276 Other current receivables, net 19,284 17,694 Assets under management 3,619 3,755 Prepaid expenses and other current assets 6,132 6,084 Total current assets 88,942 78,437 Long-term investments 45,928 47,609 Property, equipment and capitalized software, net 10,429 11,450 Goodwill 105,664 103,732 Other intangible assets, net 15,543 15,194 Other assets 17,704 17,298 Total assets $ 284,210 $ 273,720 Liabilities, redeemable noncontrolling interests and equity Current liabilities: Medical costs payable $ 34,032 $ 32,395 Accounts payable and accrued liabilities 30,738 31,958 Short-term borrowings and current maturities of long-term debt 9,787 4,274 Unearned revenues 3,206 3,355 Other current liabilities 26,668 27,072 Total current liabilities 104,431 99,054 Long-term debt, less current maturities 63,850 58,263 Deferred income taxes 4,167 3,021 Other liabilities 14,844 14,463 Total liabilities 187,292 174,801 Commitments and contingencies (Note 6) Redeemable noncontrolling interests 4,548 4,498 Equity: Preferred stock, $ 0.001 par value - 10 shares authorized; no shares issued or outstanding — — Common stock, $ 0.01 par value - 3,000 shares authorized; 920 and 924 issued and outstanding 9 9 Retained earnings 90,118 95,774 Accumulated other comprehensive loss ( 3,439 ) ( 7,027 ) Nonredeemable noncontrolling interests 5,682 5,665 Total equity 92,370 94,421 Total liabilities, redeemable noncontrolling interests and equity $ 284,210 $ 273,720 See Notes to the Condensed Consolidated Financial Statements 1 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended

View Full Filing

View this 10-Q filing on SEC EDGAR